Longer Multimorbidity Intervals Are Associated With Lower Mortality in Diabetes: A Whole-Population Nested Case-Control Study
Journal of Primary Care & Community Health · 2024
DOI: 10.1177/21501319241293950 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Journal of Primary Care & Community Health, 2024. Verfasst von Wenlong Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: The University of Hong Kong, Pok Fu Lam, Hong Kong SAR. Hauptthemen laut MEDLINE: Multimorbidity, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health and Medical Research Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Approximately two-thirds of diabetes patients develop multimorbidity, which is associated with increased mortality. We aimed to examine whether, and to what extent, the time interval between pre-existing diabetes and a second chronic disease may be associated with the risk of mortality.
Methods
We carried out a territory-wide nested case-control study using incidence density sampling, utilizing electronic health records from Hong Kong’s public healthcare facilities. Among 158 732 patients first diagnosed with diabetes from January 1, 2010 to December 31, 2012 and subsequently developed multimorbidity as of December 31, 2019, we extracted those who died before December 31, 2019 as case participants. For each participant, we randomly matched with up to 4 people of the same sex, multimorbidity age, and second chronic condition who had not died after going through the same survival period of the case participant. Multimorbidity interval was included as a continuous variable. We used conditional logistic regression to estimate adjusted odds ratios (aOR) for mortality.
Results
In total, 3508 case participants were matched with 14 032 control participants. Conditional logistic regression showed there were 19%-reduced odds of mortality following the extension of multimorbidity interval by 1 year. Similar associations were observed in men, women, people aged 64 years or younger, and older people aged 65 years or more.
Conclusions
Delayed multimorbidity among patients living with diabetes may be related to a lower risk of mortality. This study suggests that we should focus on mitigating and lowering the risk of multimorbidity in clinical management of diabetes to reduce further complication and mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The University of Hong Kong, Pok Fu Lam, Hong Kong SAR.
- Laboratory of Data Discovery for Health (D24H), Sha Tin, Hong Kong SAR.
- Advanced Data Analytics for Medical Science (ADAMS) Limited, Hong Kong SAR.
- Laboratory of Data Discovery for Health (D4H), Sha Tin, Hong Kong SAR.
- Aston University, Birmingham, UK.
ORCID-Profile: Francisco Tsz Tsun Lai
Förderung
- Health and Medical Research Fund
Zitieren
APA
Liu, W., Hu, Y., Wei, C., Zhou, L., Liu, B., Sun, Q., Chu, R. Y. K., Wan, E. Y. F., Wong, I. C. K., & Lai, F. T. T. (2024). Longer Multimorbidity Intervals Are Associated With Lower Mortality in Diabetes: A Whole-Population Nested Case-Control Study. Journal of Primary Care & Community Health. https://doi.org/10.1177/21501319241293950
Vancouver
Liu W, Hu Y, Wei C, Zhou L, Liu B, Sun Q, et al. Longer Multimorbidity Intervals Are Associated With Lower Mortality in Diabetes: A Whole-Population Nested Case-Control Study. Journal of Primary Care & Community Health. 2024. doi:10.1177/21501319241293950
BibTeX
@article{Liu2024,
author = {Liu, Wenlong and Hu, Yuqi and Wei, Cuiling and Zhou, Lingyue and Liu, Boyan and Sun, Qi and Chu, Rachel Yui Ki and Wan, Eric Yuk Fai and Wong, Ian Chi Kei and Lai, Francisco Tsz Tsun},
title = {Longer Multimorbidity Intervals Are Associated With Lower Mortality in Diabetes: A Whole-Population Nested Case-Control Study},
journal = {Journal of Primary Care & Community Health},
year = {2024},
doi = {10.1177/21501319241293950}
}
EUVIMED